
|Articles|August 21, 2006
Developing an antimicrobial strategy to combat resistance
As antimicrobial resistance continues to increase inexorably, the good news is that so far there are very few clinical situations for which there are no therapeutic options, said Robert Moellering Jr., M.D., researcher at Harvard Medical School. "But we are getting very, very close," he warned.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
2
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
3
Pharmacists as the Front Line of Vaccine Education and Access
4
A1c Monitoring Could Be Delayed Up to 2 Years for Patients With Type 2 Diabetes
5




















































































































































